Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine for diarrhoea-predominant irritable bowel syndrome
ISRCTN76612274Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Oct 2010
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in Diarrhea-predominant irritable bowel syndrome (IBS-D) comparing Mesalazine with Placebo (2 arms). Primary endpoint: Average stool frequency. Started Oct 2010; status: completed.
02
Drugs
Salcrozine
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on ISRCTN76612274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN76612274.